Dr. Pileggi's primary research interests lie in transplantation immunobiology, autoimmunity and beta cell replacement therapies. His work focuses on developing cytoprotective strategies and maximizing the number and quality of transplantable islets. In addition, he is studying ways to improve long-term engraftment to reduce the number of islets needed for each transplant procedure. Dr. Pileggi received his medical degree from the University of Pavia Medical School in Italy. He subsequently earned his Ph.D. in Experimental and Microsurgery from the same institution.